1-5 of 5
Sumithra J. Mandrekar
Close
Sort by
Journal Articles

Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma

Clinical Trials & Observations
Sarah C. Rutherford, Jun Yin, Levi D. Pederson, Kristie A. Blum, Peter Martin, Sin-Ho Jung, Barbara Grant, Cara Rosenbaum, Bruce D. Cheson, Nancy L. Bartlett, Sumithra J. Mandrekar, John P. Leonard
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1464–1468.
https://doi.org/10.1182/bloodadvances.2023012090
Published: 2024
Includes: Supplemental data
Journal Articles

Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614)

Clinical Trials & Observations
Jun Yin, Betsy LaPlant, Geoffrey L. Uy, Guido Marcucci, William Blum, Richard A. Larson, Richard M. Stone, Sumithra J. Mandrekar
Journal: Blood Advances
Blood Adv (2019) 3 (11): 1714–1721.
https://doi.org/10.1182/bloodadvances.2018026112
Published: 2019
Includes: Supplemental data
Journal Articles

Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance)

Clinical Trials & Observations
Gail J. Roboz, Sumithra J. Mandrekar, Pinkal Desai, Kristina Laumann, Alison R. Walker, Eunice S. Wang, Jonathan E. Kolitz, Bayard L. Powell, Eyal C. Attar, Wendy Stock, Clara D. Bloomfield, Jessica Kohlschmidt, Krzysztof Mrózek, Duane C. Hassane, Levi Garraway, Judit Jané-Valbuena, Michele Baltay, Adam Tracy, Guido Marcucci, Richard M. Stone, Richard A. Larson
Journal: Blood Advances
Blood Adv (2018) 2 (24): 3608–3617.
https://doi.org/10.1182/bloodadvances.2018023689
Published: 2018
Includes: Supplemental data
Journal Articles

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)

Clinical Trials & Observations
John C. Byrd, Amy S. Ruppert, Nyla A. Heerema, Alese E. Halvorson, Eva Hoke, Mitchell R. Smith, John E. Godwin, Stephen Couban, Todd A. Fehniger, Michael J. Thirman, Martin S. Tallman, Frederick R. Appelbaum, Richard M. Stone, Sue Robinson, Julie E. Chang, Sumithra J. Mandrekar, Richard A. Larson
Journal: Blood Advances
Blood Adv (2018) 2 (14): 1705–1718.
https://doi.org/10.1182/bloodadvances.2017015396
Published: 2018
Includes: Supplemental data
Journal Articles

A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3 -mutated acute myeloid leukemia: CALGB 11001

Clinical Trials & Observations
Geoffrey L. Uy, Sumithra J. Mandrekar, Kristina Laumann, Guido Marcucci, Weiqiang Zhao, Mark J. Levis, Heidi D. Klepin, Maria R. Baer, Bayard L. Powell, Peter Westervelt, Daniel J. DeAngelo, Wendy Stock, Ben Sanford, William G. Blum, Clara D. Bloomfield, Richard M. Stone, Richard A. Larson
Journal: Blood Advances
Blood Adv (2017) 1 (5): 331–340.
https://doi.org/10.1182/bloodadvances.2016003053
Published: 2017